US › Healthcare

CVRx Inc (CVRX)

US · Healthcare · Medical Devices

$5.49-0.18%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$14.8M
Revenue YoY
+19.6%
Net profit
$-13.1M
Profit YoY
+4.7%
EPS
$-0.50
EPS estimate
$-0.50
Net margin
-88.8%

EPS came in at -0.50 against a street estimate of -0.50 — a beat of 0.0%.

Key statistics

Market cap
$137.3M
Forward P/E
0.0
P/B
4.72
Book value
$1.10
EPS (TTM)
$-2.01
52-week high
$11.30
52-week low
$4.37
50-day MA
$5.31
200-day MA
$7.33
Beta
0.78

Analyst view

Analysts rate CVRx Inc a strong buy (6 buy, 1 hold, 0 sell out of 7) with an average price target of $11.17.

Shareholding

Insiders
9.55%
Institutions
63.85%

Largest institutional holders

FundStake
Johnson & Johnson15.17%
NEA Management Company, LLC7.64%
BlackRock Inc3.87%
GSK PLC3.80%
Vanguard Capital Management, LLC3.43%
Royal Bank of Canada2.66%
Balyasny Asset Management LLC2.38%
Silvercrest Asset Management Group LLC2.16%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for CVRx Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.